Contraceptives Drugs and Devices Market to Reach USD 15.3 Billion by 2020

Contraceptives Drugs and Devices Market – Global Contraceptive Products Analysis and Forecast 2013-2020, estimates the global contraceptive drugs and devices market to reach nearly USD 15.3 Billion in 2020, at a CAGR of 3.5% from 2016 to 2020 - iHealthcareAnalyst, Inc.

Visit the Contraceptives Drugs and Devices Market – Global Contraceptive Products Analysis and Forecast 2013-2020 report at http://www.ihealthcareanalyst.com/report/contraceptives-drugs-devices-market/ 

Different types of birth control methods have large differences in effectiveness, actions required of users, and side effects. The effective contraceptive methods of birth control include intrauterine and implantable birth control devices followed by a number of hormone based methods including oral pills, patches, vaginal rings, and injections. Other methods include physical barriers such as condoms, diaphragms and birth control sponges. The global contraceptive drugs and devices market report estimates the market size (Revenue USD million - 2013 to 2020) for key market segments based on the drug type (oral, injectable and topical drugs), device type (diaphragms, sponges, vaginal rings, male and female condoms, intrauterine, non-surgical and sub-dermal devices and implants), and forecasts growth trends (CAGR% - 2016 to 2020). It also provides the detailed market landscape and profiles of major competitors in the global market including company overview, financial snapshot, major products and services offered, and recent trends in strategic management.

The global contraceptive drugs and devices market is segmented as:

1. Drug 

1.1 Injectable

1.2 Oral Pills

1.3 Topical Drugs

2. Device

2.1 Diaphragm (Cervical Cap/Shield)

2.2 Female Condoms

2.3 Intrauterine Devices (IUDs)

2.4 Male Condoms

2.5 Non-Surgical Permanent Devices

2.6 Sponges

2.7 Sub-Dermal Implants

2.8 Vaginal Rings

3. Geography (Region, Country)

3.1 North America (U.S., Canada

3.2 Latin America (Brazil, Mexico, Rest of LA)

3.3 Europe (U.K., Germany, France, Italy, Spain, Rest of EU)

3.4 Asia Pacific (Japan, China, India, Rest of APAC)

3.5 Rest of the World

4. Company Profiles

4.1 Actavis, Inc.

4.2 Bayer AG

4.3 Church & Dwight Co., Inc.

4.4 Cooper Surgical, Inc.

4.5 Mayer Laboratories, Inc.

4.6 Merck & Co., Inc.

4.7 Pfizer, Inc.

4.8 Reckitt Benckiser plc.

4.9 Teva Pharmaceutical Industries Ltd.

4.10 The Female Health Company

About Us

iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.

Contact Us

iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareranalyst.com
Website: http://www.ihealthcareanalyst.com